- Home
- ARVN vs ACNB Comparison
ARVN vs ACNB Comparison
Compare ARVN & ACNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- ACNB
- Stock Information
- Founded
- ARVN 2015
- ACNB 1857
- Country
- ARVN United States
- ACNB United States
- Employees
- ARVN N/A
- ACNB N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- ACNB Major Banks
- Sector
- ARVN Health Care
- ACNB Finance
- Exchange
- ARVN Nasdaq
- ACNB Nasdaq
- Market Cap
- ARVN 456.2M
- ACNB 450.1M
- IPO Year
- ARVN 2018
- ACNB N/A
- Fundamental
- Price
- ARVN $6.79
- ACNB $44.57
- Analyst Decision
- ARVN Buy
- ACNB Strong Buy
- Analyst Count
- ARVN 22
- ACNB 3
- Target Price
- ARVN $20.21
- ACNB $50.00
- AVG Volume (30 Days)
- ARVN 2.1M
- ACNB 20.1K
- Earning Date
- ARVN 08-06-2025
- ACNB 07-24-2025
- Dividend Yield
- ARVN N/A
- ACNB 3.06%
- EPS Growth
- ARVN N/A
- ACNB N/A
- EPS
- ARVN N/A
- ACNB 2.69
- Revenue
- ARVN $372,800,000.00
- ACNB $123,053,000.00
- Revenue This Year
- ARVN $7.57
- ACNB $40.18
- Revenue Next Year
- ARVN N/A
- ACNB $4.83
- P/E Ratio
- ARVN N/A
- ACNB $16.54
- Revenue Growth
- ARVN 299.57
- ACNB 15.31
- 52 Week Low
- ARVN $5.90
- ACNB $35.37
- 52 Week High
- ARVN $29.61
- ACNB $50.72
- Technical
- Relative Strength Index (RSI)
- ARVN 41.59
- ACNB 63.80
- Support Level
- ARVN $6.06
- ACNB $42.10
- Resistance Level
- ARVN $7.83
- ACNB $42.24
- Average True Range (ATR)
- ARVN 0.40
- ACNB 0.94
- MACD
- ARVN -0.11
- ACNB 0.14
- Stochastic Oscillator
- ARVN 34.93
- ACNB 95.69
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About ACNB ACNB Corporation
ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.